Researchers from FabRx are working on using 3D Printing to create personalized medicine for patients that could reduce the adverse effects to individuals. Though FDM 3D Printing has potential, the high extrusion temperature limits the potential active ingredients to only heat-stable ones, it was still chosen over SLA 3D Printing since it was unsafe. A regenHU 3D bioprinter was used to print paracetamol into three different tablet geometries – solid, ring and mesh and the results could be invariably beneficial if successful for the individual personalization of medicines.

Source: https://link.springer.com/article/10.1208/s12249-018-1107-z